The role of the transcription factor DP in apoptosis

Apoptosis

Volumn 8, Issue 5, 2003, Pages 461-468

  Hitchens, M R ^a   Robbins, Paul D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; DP; E2F

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; PROTEIN KINASE; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR DP2; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

APOPTOSIS; CELL CYCLE; CELL FUNCTION; CELL SURVIVAL; DNA BINDING; DNA SYNTHESIS; GENE TARGETING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; UPREGULATION;

ANIMALS; APOPTOSIS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; HUMANS; MICE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0141996462     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025586207239     Document Type: Review

References (89)

1. Girling R, Partridge JF, Bandara LR, et al. A new component of the transcription factor DRTF1/E2F. Nature 1993; 362: 83-87.
2. Helin K, Wu CL, Fattaey AR, et al. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev 1993; 7: 1850-1861.
3. DeGregori J. The genetics of the E2F family of transcription factors: Shared functions and unique roles. BBA 2002; 1602: 131-150.
4. Bandara LR, Buck VM, Zamanian M, Johnston LH, La Thangue NB. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2E EMBO J 1993; 12: 4317-4324.
5. Krek W, Livingston DM, Shirodkar S. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 1993; 262: 1557-1560.
6. Wu CL, Zukerberg LR, Ngwu C, Harlow E, Lees AJ. In vivo association of E2F and DP family proteins. Mol Cell Biol 1995; 15: 2536-2546.
7. Ormondroyd E, de la Luna S, La Thangue NB. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F. Oncogene 1995; 11: 1437-1446.
8. Zhang Y, Chellappan SP. Cloning and characterization of human DP2, a novel dimerization partner of E2F. Oncogene 1995; 10: 2085-2093.
9. Rogers KT, Higgins PDR, Milla MM, Phillips RS, Horowitz JM. DP-2 a heterodimeric partner of E2F: Identification and characterization of DP-2 proteins expressed in vivo. Proc Natl Acad Sci USA 1996; 93: 7594-7599.
10. Mariconti L, Pellegrini B, Cantoni R, et al. The E2F family of transcription factors from Arabidopsis thaliana. Novel and conserved components of the retinoblastoma/E2F pathway in plants. J Biol Chem 2002; 277: 9911-9919.
11. Hao XF, Alphey L, Bandara LR, Lam EW, Glover D, La Thangue NB. Functional conservation of the cell cycle-regulating transcription factor DRTF1/E2F and its pathway of control in Drosophila melanogaster. J Cell Sci 1995; 108: 2945-2954.
12. Dyson N. The regulation of E2F by pRB-family members. Genes Dev 1998; 12: 2245-2262.
13. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 1997; 94: 7245-7250.
14. Shan B, Farmer AA, Lee WH. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis. Cell Growth Differ 1996; 7: 689-697.
15. Holmberg C, Helin K, Sehested M, Karlstrom O. E2F-1-induced p53-independent apoptosis in transgenic mice. Oncogene 1998; 17: 143-155.
16. Wang D, Russell J, Xu H, Johnston DG. Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis. Mol Carcinog 2001; 31: 90-100.
17. Jooss K, Lam EWF, Bybee A, Girling R, Muller R, La Thangue NB. Proto-oncogenic properties of the DP family of proteins. Oncogene 1995; 10: 1529-1536.
18. Cartwright P, Muller H, Wagener C, Holm K, Helin K. E2F-6: A novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene 1998; 17: 611-623.
19. Kouzarides T. Transcriptional control by the retinoblastoma protein. Seminars in Cancer Bio 1995; 6: 91-98.
20. Suzuki M, Okuyama S, Okamoto S, et al. A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer. Oncogene 1998; 17: 853-865.
21. Strachan GD, Jordan-Sciutto KL, Rallapalli R, Tuan RS, Hall DJ. The E2F-1 transcription factor is negatively regulated by its interaction with the MDMX protein. J Cell Biochem 2003; 88:557-568.
22. Martin K, Trouche D, Hagemeier C, Sorensen TS, La Thangue NB, Kouzarides T. Nature 1995; 375: 691-694.
23. Eymin B, Karayan L, Seite P, et al. Human ARF binds E2F1 and inhibits its transcriptional activity. Oncogene 2001; 20: 1033-1041.
24. Loughran O, La Thangue NB. Apoptotic and growth-promoting activity of E2F modulated by MDM2. Mol Cell Biol 2000; 20: 2186-2197.
25. Nip J, Strom DK, Eischen CM, Cleveland JL, Zambetti GP, Hiebert SW. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation. Oncogene 2001; 20: 910-920.
26. Sorensen TS, Girling R, Lee CW, Gannon J, Bandara LR, La Thangue NB. Functional Interaction between DP-1 and p53. Mol Cell Biol 1996; 16: 5888-5895.
27. Hsu SI, Yang CM, Sim KG, Hentschel DM, O'Leary E, Bonventre JV. TRIP-Br: A novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1. EMBO J 2001; 20: 2273-2285.
28. Bandara LR, Lam EW, Sorensen TS, Zamanian M, Girling R, La Thangue NB. DP-1: A cell cycle-regulated and phosphorylated component of transcription factor DRTF1/E2F which is functionally important for recognition by pRb and the adenovirus E4 orf 6/7 protein. EMBO J 1994; 13: 3104-3114.
29. Krek W, Ewen ME, Shirodkar S, Arany Z, Kaelin Jr WG, Livingston DM. Negative regulation of the growth-promoting transcription factor E2F-1 by a stable bound cyclin A-dependent protein kinase. Cell 1994; 78: 161-172.
30. Xu M, Sheppard KA, Peng CY, Yee AS, Piwnica-Worms H. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol Cell Biol 1994; 14: 8420-8431.
31. Dynlacht BD, Moberg K, Lees JA, Harlow E, Zhu L. Specific regulation of E2F family members by cyclin-dependent kinases. Mol Cell Biol 1997; 17: 3867-3875.
32. Krek W, Xu G, Livingston DM. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 1995; 83: 1149-1158.
33. Peeper DS, Keblusek P, Helin K, Toebes M, van der EB AJ, Zantema A. Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro. Oncogene 1995; 10: 39-48.
34. Wang S, Nath N, Minden A, Chellappan. Regulation of Rb and E2F by signal transduction cascades: Divergent effects of JNK1 and p38 kinases. EMBO J 1999; 18: 1559-1570.
35. Altiok S, Xu M, Spiegelman BM. PPARγ induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev 1997; 11: 1987-1998.
36. Magae J, Wu CL, Illenye S, Harlow E, Heintz NH. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. J Cell Sci 1996; 109: 1717-1726.
37. Verona R, Moberg K, Estes S, Starz M, Vernon JP, Lees JA. E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol Cell Biol 1997; 17: 7268-7282.
38. de la Luna S, Burden MJ, Lee CW, La Thangue NB. Nuclear accumulation of the E2F heterodimer regulated by subunit composition and alternative splicing of a nuclear localization signal. J Cell Sci 1996; 109: 2443-2452.
39. Linderman GJ, Gaubatz S, Livingston DM, Ginsberg D. The subcellular localization of E2F-4 is cell-cycle dependent. Proc Natl Acad Sci USA 1997; 94: 5095-5100.
40. Moberg K, Starz MA, Lees JA. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol 1996;16:1436-1449.
41. Puri PL, Cimino L, Fulco M, et al. Regulation of E2F4 mitogenic activity during terminal differentiation by its heterodimerization partners for nuclear translocation. Cancer Res 1998;58:1325-1331.
42. Allen KE, de la Luna S, Kerkhoven RM, Bernards R, La Thangue NB. Distinct mechanisms of nuclear accumulation regulate the functional consequences of E2F transcription factors. J Cell Sci 1997; 110: 2819-2831.
43. de la Luna S, Allen KE, Mason SL, La Thangue NB. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor. EMBO J 1999; 18:212-228.
44. Nili E, Cojocaru GS, Kalma Y, et al. Nuclear membrane protein LAP2beta mediates transcriptional repression alone and together with its binding partner GCL (germ-cell-less). J Cell Sci 2001; 114: 3297-3307.
45. Hateboer G, Kerkhoven RM, Shvarts A, Bernards R, Beijersbergen RL. Degradation of E2F by the ubiquitin-proteasome pathway: Regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev 1996; 10: 2960-2970.
46. Lin WC, Lin FT, Nevins JR. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 2001; 15: 1833-1844.
47. Magae J, Illenye S, Chang YC, Mitsu Y, Heintz NH. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1. Oncogene 1999; 18: 593-605.
48. Wu X, Levine AJ. p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 1994; 91: 3602-3606.
49. Kowalik TF, DeGregori J, Schwarz JK, Nevins JR. E2F-1 overexpression in quiescent fibroblast leads to induction of cellular DNA synthesis and apoptosis. J Virol 1995; 69: 2491-2500.
50. Shan B, Lee WH. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 1994; 14: 8166-8173.
51. Qin XQ, Livingston DM, Kaelin Jr WG, Adams PD. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA 1994; 91: 10918-10922.
52. Wang D, Russell JL, Johnson DG. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogeneic properties in vivo. Mol Cell Biol 2000; 20: 3417-3424.
53. Field SJ, Tsai FY, Kuo F, et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996; 85: 549-561.
54. Garcia I, Murga M, Vicario A, Field SJ, Zubiaga AM. A role for E2F1 in the induction of apoptosis during thymic negative selection. Cell Growth Differ 2000; 11: 91-98.
55. Zhu JW, DeRyckere D, Li FX, Wan YY, DeGregori J. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection. Cell Growth Differ 1999; 10: 829-838.
56. Pan H, Yin C, Dyson NJ, Harlow E, Yamasaki L, Van Dyke T. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol Cell 1998; 2: 283-292.
57. Saavedra HI, Wu L, de Bruin A, et al. Specificity of E2F1, E2F2 and E2F3 in mediating phenotypes induced by loss of Rb. Cell Growth Differ 2002; 13: 215-225.
58. Hou ST, Cowan E, Walker T, et al. The transcription factor E2F1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation. J Neurochem 2001; 78: 287-297.
59. Palmero I, Murga M, Zubiaga, Serrano M. Activation of ARF by oncogenic stress in mouse fibroblasts in independent of E2F1 and E2F2. Oncogene 2002; 21: 2939-2947.
60. Ziebold U, Reza T, Caron A, Lees, JA. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev 2001; 15: 386-391.
61. Hiebert SW, Packham G, Strom DK, et al. E2F-1:DP-1 induces p53 and overrides survival factors to induce apoptosis. Mol Cell Biol 1995; 15: 6864-6874.
62. Kowalik TF, DeGregori J, Leone G, Jakoi L, Nevins JR. E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. Cell Growth Differ 1998; 9: 113-118.
63. Bates S, Phillips AC, Clark PA, et al. p14ARF links the tumor suppressors RB and p53. Nature 1998; 395: 124-125.
64. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995; 83: 993-1000.
65. Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF, Sherr CJ. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci USA 1998; 95: 8292-8297.
66. Stott FJ, Bates S, James MC, et al. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 1998 17: 5001-5014.
67. Pomerantz J, Schreiber-Agus N, Liegeois NJ, et al. The Ink4a tumor suppressor gene product, p19arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998; 92: 713-723.
68. deStanchina E, McCurrach ME, Zindy F, et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev 1998; 12: 2434-2442.
69. Tolbert D, Lu X, Yin C, Tantama M, Van Dyke T. p19ARF is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo. Mol Cell Biol 2002; 22: 370-377.
70. Russell JL, Powers JT, Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG. ARF differentially modulates apoptosis induced by E2F1 and Myc. Mol Cell Biol 2002; 22: 1360-1368.
71. Rogoff HA, Pickering MT, Debatis ME, Jones S, Kowalik TF. E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis. Mol Cell Biol 2002;22:5308-5318.
72. Martelli F, Hamilton T, Silver DP, et al. pARF targets certain E2F species for degradation. Proc Natl Acad Sci USA 2001; 98: 4455-4460.
73. Banin S, Moyal L, Shieh S, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998; 281: 1674-1677.
74. Canman CE, Lim DS, Cimprich KA, et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998; 281: 1677-1679.
75. Shieh SY, Ahn J, Tamai K, Taya Y, Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev 2000; 14: 289-300.
76. Berkovich E, Ginsberg D. ATM is a target for positive regulation by E2F-1. Oncogene 2003; 22: 161-167.
77. Hsieh JK, Yap D, O'Connor DJ, et al. Novel function of the cyclin a binding site of E2F in regulating p53-induced apoptosis in response to DNA damage. Mol Cell Biol 2002; 22: 78-93.
78. O'Connor DJ, Lam EW, Griffin S, et al. Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1. EMBO J 1995; 14: 184-192.
79. Putzer BM, Stiewe T, Parssanedjad K, Rega S, Esche H. E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene products. Cell Death Differ 2000; 7: 177-188.
80. Stiewe T, Putzer BM. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nature Genet 2000; 26: 464-469.
81. Zaika A, Irwin M, Sansome C, Moll UM. Oncogenes induce and activate endogenous p73 protein. J Biol Chem 2001; 276: 113310-11316.
82. Budd RC. Activation-induced cell death. Curr Opin Immunol 2001; 13: 356-362.
83. Nahle Z, Polakoff J, Davuluri RV, et al. Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol 2002; 4: 859-864.
84. Moroni MC, Hickman ES, Denchi EL, et al. Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 2001; 3: 552-558.
85. Guo Z, Yikang S, Yoshida H, Mak TW, Zacksenhaus E. Inactivation of the retinoblastoma tumor suppressor induces Apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis. Cancer Res 2001; 61: 8395-8400.
86. Stanelle J, Stiewe T, Theseling CC, Peter M, Putzer BM. Gene expression changes in response to E2F1 activation. Nuc Acids Res 2002; 30: 1859-1867.
87. Barkett M, Gilmore TD. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 1999; 18: 6910-6924.
88. Phillips AC, Ernst MK, Bates S, Rice NR, Vousden KH. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell 1999; 4: 771-781.
89. Tanak H, Matsumura I, Ezoe S, et al. E2F1 and c-Myc potentiate apoptosis through inhibition of NF-κB activity that facilitates MnSOD-mediated ROS elimination. Mol Cell 2002; 9: 1017-1029.